Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providersHematology & Oncology Physician in Geneva, IL
NPI: 1235143835Primary Practice Location
NORTHWESTERN MEDICINE DELNOR COMMUNITY HOSPITAL
300 Randall Rd, Geneva, IL
Primary Employer
Northwestern Medical Group
nm.org
HQ Phone
Get M.D. Christopher's Phone NumberMobile
Get M.D. Christopher's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardIL State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 200 | 584 |
| 2 | 99223Initial hospital inpatient care, typically 70 minutes per day | 77 | 79 |
| 3 | 99233Subsequent hospital inpatient care, typically 35 minutes per day | 65 | 102 |
| 4 | 99442Physician telephone patient service, 11-20 minutes of medical discussion | 54 | 75 |
| 5 | 99232Subsequent hospital inpatient care, typically 25 minutes per day | 39 | 49 |
Web-Based Cancer Symptom Self-Management System: A Randomized Clinical Trial.
Lead Sponsor: Alliance for Clinical Trials in Oncology
Collaborators: National Cancer Institute (NCI)
Intervention / Treatment: OTHER: Placebo, DRUG: Dexamethasone, DRUG: Olanzapine, DRUG: Palonosetron Hydrochloride, DRUG: Ondansetron Hydrochloride, DRUG: Fosaprepitant Dimeglumine
Lead Sponsor: ECOG-ACRIN Cancer Research Group
Collaborators: National Cancer Institute (NCI)
Intervention / Treatment: OTHER: Laboratory Biomarker Analysis, OTHER: Pharmacological Study, DRUG: Prednisone, DRUG: Antiandrogen Therapy, DRUG: Cabazitaxel, DRUG: Abiraterone Acetate, PROCEDURE: Orchiectomy
Lead Sponsor: Calithera Biosciences, Inc
Intervention / Treatment: DRUG: Placebo, DRUG: Cabozantinib, DRUG: CB-839
